Adaptive Biotechnologies Corp (ADPT) · Fund holders
Which of the 64 well-known fund managers followed here own Adaptive Biotechnologies, from the 13F each files after a quarter's end, and what each did in its latest quarter.
Held by
5
of 64 funds
Their stake
$692.86M
together
Bought
0
0 new, 0 added
Sold
4
1 sold out
The funds
| Fund | Share of its portfolio | Shares | Value | Latest quarter |
|---|---|---|---|---|
| Viking Global Investors2026-06-30 | 1.83% | 29,993,708 | $643.37M | Unchanged |
| ARK Investment Management (Cathie Wood)2026-06-30 | 0.29% | 2,090,306 | $44.84M | Unchanged |
| Polen Capital Management2026-06-30 | 0.02% | 102,457 | $2.20M | Reduced 12% |
| Gotham Asset Management (Joel Greenblatt)2026-06-30 | 0.00% | 74,732 | $1.60M | Reduced 18% |
| Bridgewater Associates2026-06-30 | 0.00% | 40,087 | $859,866 | Reduced 55% |
| Point72 Asset Management (Steve Cohen)2026-06-30 | 0.00% | 0 | – | Sold out |
A 13F shows a quarter's end and is filed up to 45 days later, so this is not what the funds hold today. All funds ›